Skip to main content

Table 1 Baseline characteristics of the enrolled patients in each group

From: Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

  A20E10 (n = 48) A40 (n = 50) P value
Age(yrs) 56 ± 11 57 ± 8 0.6014
Male/Female 35/13 36/14 0.8207
TC(mmol/L) 4.91 ± 0.95 4.82 ± 0.73 0.645
TG(mmol/L) 1.89 ± 0.73 1.74 ± 0.79 0.332
HDL-C(mmol/L) 1.07 ± 0.25 1.14 ± 0.31 0.195
LDL-C(mmol/L) 3.31 ± 0.89 3.20 ± 0.90 0.540
Non-HDL-C(mmol/L) 3.91 ± 0.91 3.56 ± 0.78 0.077
Lp(a) (mg/L) 222 ± 215 160 ± 195 0.140
ApoB(mmol/L) 1.09 ± 0.29 1.10 ± 0.26 0.774
Apa A1(mmol/L) 1.30 ± 0.33 1.45 ± 0.45 0.063
ALT(U/L) 23.44 ± 15.36 19.90 ± 10.84 0.190
AST(U/L) 19.89 ± 5.99 17.80 ± 6.02 0.089
TBil(umol/L) 14.26 ± 4.19 13.96 ± 4.28 0.722
DBil(umol/L) 2.30 ± 0.64 2.34 ± 0.71 0.748
Cr(umol/L) 77.69 ± 15.57 73.36 ± 14.79 0.163
BUN(mmol/L) 5.05 ± 1.07 5.28 ± 1.16 0.327
CK(U/L) 82.13 ± 35.11 107.60 ± 117.44 0.157
FBG(mmol/L) 5.34 ± 1.00 5.76 ± 1.24 0.075
HsCRP(mg/dL) 1.74 ± 1.97 2.45 ± 3.00 0.178
ox-LDL(U/L) 6.04 ± 2.00 6.04 ± 2.00 0.998
  1. Notes: TC Total cholesterol, TG Triglyceride, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, Lp(a) Lipoprotein a, ApoB Apolipoprotein B, ApoAI ApolipoproteinAI, ALT Alanine aminotransferase, AST Aspartate Transaminase, TBil Total Bilirubin, DBil Direct Bilirubin, Cr Creatinine, CK Creatine Kinase, UA Uric Acid, FBG Fasting Blood Glucose, HsCRP High sensitive C- Reactive Protein, ox-LDL oxidation low-density lipoprotein
  2. A20E10 indicates the patients who received Atorvastatin 20 mg qn plus Ezetimibe 10 mg qd,A40 indicates the patients who received Atorvastatin 40 mg qn